126 related articles for article (PubMed ID: 21780129)
1. Relationship of interleukin-8 gene polymorphisms with hepatocellular carcinoma susceptibility and pathological development.
Chien MH; Yeh CB; Li YC; Wei LH; Chang JH; Peng YT; Yang SF; Kuo WH
J Surg Oncol; 2011 Dec; 104(7):798-803. PubMed ID: 21780129
[TBL] [Abstract][Full Text] [Related]
2. TIMP-3 -1296 T>C and TIMP-4 -55 T>C gene polymorphisms play a role in the susceptibility of hepatocellular carcinoma among women.
Tsai HT; Hsieh MJ; Chiou HL; Lee HL; Hsin MC; Liou YS; Yang CC; Yang SF; Kuo WH
Tumour Biol; 2014 Sep; 35(9):8999-9007. PubMed ID: 24903383
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population.
Li S; Deng Y; Chen ZP; Huang S; Liao XC; Lin LW; Li H; Peng T; Qin X; Zhao JM
Infect Genet Evol; 2011 Dec; 11(8):2083-8. PubMed ID: 22019522
[TBL] [Abstract][Full Text] [Related]
4.
Pan X; Li M; Huang L; Mo D; Liang Y; Huang Z; Zhu B; Fang M
Biomed Res Int; 2020; 2020():2918517. PubMed ID: 33062675
[TBL] [Abstract][Full Text] [Related]
5. Effects of E-cadherin (CDH1) gene promoter polymorphisms on the risk and clinicopathological development of hepatocellular carcinoma.
Chien MH; Yeh KT; Li YC; Hsieh YH; Lin CH; Weng MS; Kuo WH; Yang SF
J Surg Oncol; 2011 Sep; 104(3):299-304. PubMed ID: 21462191
[TBL] [Abstract][Full Text] [Related]
6. Effect of RECK gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathologic features.
Chung TT; Yeh CB; Li YC; Su SC; Chien MH; Yang SF; Hsieh YH
PLoS One; 2012; 7(3):e33517. PubMed ID: 22428065
[TBL] [Abstract][Full Text] [Related]
7. Association of Interleukin-8 Gene Polymorphisms and Expression with Hepatocellular Carcinoma in Egyptian Patients with Liver Cirrhosis.
Hassanin OM; El-Masry TM; El-Baz A; Adel-Abou-Zaghla HM
Egypt J Immunol; 2017 Jan; 24(1):143-152. PubMed ID: 29120586
[TBL] [Abstract][Full Text] [Related]
8. Impact of interleukin IL-6 rs-1474347 and IL-10 rs-1800896 genetic polymorphisms on the susceptibility of HCV-infected Egyptian patients to hepatocellular carcinoma.
Abd El-Baky RM; Hetta HF; Koneru G; Ammar M; Shafik EA; Mohareb DA; Abbas El-Masry M; Ramadan HK; Abu Rahma MZ; Fawzy MA; Fathy M
Immunol Res; 2020 Jun; 68(3):118-125. PubMed ID: 32504406
[TBL] [Abstract][Full Text] [Related]
9. Association of IL-2 polymorphisms and IL-2 serum levels with susceptibility to HBV-related hepatocellular carcinoma in a Chinese Zhuang population.
Peng Q; Li H; Lao X; Deng Y; Chen Z; Qin X; Li S
Infect Genet Evol; 2014 Oct; 27():375-81. PubMed ID: 25173083
[TBL] [Abstract][Full Text] [Related]
10. Survivin T9809C, an SNP located in 3'-UTR, displays a correlation with the risk and clinicopathological development of hepatocellular carcinoma.
Hsieh YS; Tsai CM; Yeh CB; Yang SF; Hsieh YH; Weng CJ
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S625-33. PubMed ID: 22052111
[TBL] [Abstract][Full Text] [Related]
11. Correlation of Chitinase 3-Like 1 Single Nucleotide Polymorphisms with Hepatocellular Carcinoma in Taiwan.
Huang WS; Lin HY; Yeh CB; Chen LY; Chou YE; Yang SF; Liu YF
Int J Med Sci; 2017; 14(2):136-142. PubMed ID: 28260989
[TBL] [Abstract][Full Text] [Related]
12. Association between polymorphisms of the
He XT; Xu HQ; Wang XM; He XS; Niu JQ; Gao PJ
World J Gastroenterol; 2017 Jan; 23(2):232-241. PubMed ID: 28127197
[TBL] [Abstract][Full Text] [Related]
13. Association of single nucleotide polymorphisms in VDR and DBP genes with HBV-related hepatocellular carcinoma risk in a Chinese population.
Peng Q; Yang S; Lao X; Li R; Chen Z; Wang J; Qin X; Li S
PLoS One; 2014; 9(12):e116026. PubMed ID: 25541958
[TBL] [Abstract][Full Text] [Related]
14. Association of CD44 polymorphisms and susceptibility to HBV-related hepatocellular carcinoma in the Chinese population.
Deng Y; Chen ZJ; Lan F; He QT; Chen SY; Du YF; Li S; Qin X
J Clin Lab Anal; 2019 Oct; 33(8):e22977. PubMed ID: 31301090
[TBL] [Abstract][Full Text] [Related]
15. Impacts of CCL4 gene polymorphisms on hepatocellular carcinoma susceptibility and development.
Wang B; Chou YE; Lien MY; Su CM; Yang SF; Tang CH
Int J Med Sci; 2017; 14(9):880-884. PubMed ID: 28824325
[TBL] [Abstract][Full Text] [Related]
16. Effects of HMGB1 Polymorphisms on the Susceptibility and Progression of Hepatocellular Carcinoma.
Wang B; Yeh CB; Lein MY; Su CM; Yang SF; Liu YF; Tang CH
Int J Med Sci; 2016; 13(4):304-9. PubMed ID: 27076788
[TBL] [Abstract][Full Text] [Related]
17. Role of IL-4 gene polymorphisms in HBV-related hepatocellular carcinoma in a Chinese population.
Lu Y; Wu Z; Peng Q; Ma L; Zhang X; Zhao J; Qin X; Li S
PLoS One; 2014; 9(10):e110061. PubMed ID: 25295591
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection.
Wang Y; Kato N; Hoshida Y; Yoshida H; Taniguchi H; Goto T; Moriyama M; Otsuka M; Shiina S; Shiratori Y; Ito Y; Omata M
Hepatology; 2003 Jan; 37(1):65-71. PubMed ID: 12500190
[TBL] [Abstract][Full Text] [Related]
19. +49G > A polymorphism in the cytotoxic T-lymphocyte antigen-4 gene increases susceptibility to hepatitis B-related hepatocellular carcinoma in a male Chinese population.
Gu X; Qi P; Zhou F; Ji Q; Wang H; Dou T; Zhao Y; Gao C
Hum Immunol; 2010 Jan; 71(1):83-7. PubMed ID: 19778566
[TBL] [Abstract][Full Text] [Related]
20. hTERT rs2736098 genetic variants and susceptibility of hepatocellular carcinoma in the Chinese population: a case-control study.
Zhang C; Tian YP; Wang Y; Guo FH; Qin JF; Ni H
Hepatobiliary Pancreat Dis Int; 2013 Feb; 12(1):74-9. PubMed ID: 23392802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
